vs

Side-by-side financial comparison of SurgePays, Inc. (SURG) and Americas Gold & Silver Corp (USAS). Click either name above to swap in a different company.

Americas Gold & Silver Corp is the larger business by last-quarter revenue ($19.1M vs $16.2M, roughly 1.2× SurgePays, Inc.). Americas Gold & Silver Corp runs the higher net margin — -82.3% vs -85.6%, a 3.3% gap on every dollar of revenue. On growth, SurgePays, Inc. posted the faster year-over-year revenue change (68.7% vs -28.0%).

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

Pan American Silver Corporation is a mining company based in Canada with operations in Latin America. The company has mines and other projects in Mexico, Peru, Bolivia, and Argentina.

SURG vs USAS — Head-to-Head

Bigger by revenue
USAS
USAS
1.2× larger
USAS
$19.1M
$16.2M
SURG
Growing faster (revenue YoY)
SURG
SURG
+96.7% gap
SURG
68.7%
-28.0%
USAS
Higher net margin
USAS
USAS
3.3% more per $
USAS
-82.3%
-85.6%
SURG

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
SURG
SURG
USAS
USAS
Revenue
$16.2M
$19.1M
Net Profit
$-13.9M
$-15.7M
Gross Margin
-14.8%
34.2%
Operating Margin
-79.1%
Net Margin
-85.6%
-82.3%
Revenue YoY
68.7%
-28.0%
Net Profit YoY
30.0%
2.8%
EPS (diluted)
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SURG
SURG
USAS
USAS
Q4 25
$16.2M
Q3 25
$18.7M
$19.1M
Q2 25
$11.5M
Q1 25
$10.6M
Q4 24
$9.6M
Q3 24
$4.8M
$26.5M
Q2 24
$15.1M
Q1 24
$31.4M
Net Profit
SURG
SURG
USAS
USAS
Q4 25
$-13.9M
Q3 25
$-7.5M
$-15.7M
Q2 25
$-7.1M
Q1 25
$-7.6M
Q4 24
$-19.8M
Q3 24
$-14.3M
$-16.2M
Q2 24
$-12.9M
Q1 24
$1.2M
Gross Margin
SURG
SURG
USAS
USAS
Q4 25
-14.8%
Q3 25
-13.9%
34.2%
Q2 25
-23.0%
Q1 25
-27.8%
Q4 24
-117.0%
Q3 24
-164.2%
23.6%
Q2 24
-22.8%
Q1 24
26.0%
Operating Margin
SURG
SURG
USAS
USAS
Q4 25
-79.1%
Q3 25
-37.2%
Q2 25
-59.1%
Q1 25
-71.7%
Q4 24
-209.0%
Q3 24
-299.4%
Q2 24
-72.1%
Q1 24
5.6%
Net Margin
SURG
SURG
USAS
USAS
Q4 25
-85.6%
Q3 25
-40.1%
-82.3%
Q2 25
-61.5%
Q1 25
-72.2%
Q4 24
-206.5%
Q3 24
-299.3%
-60.9%
Q2 24
-85.3%
Q1 24
3.9%
EPS (diluted)
SURG
SURG
USAS
USAS
Q4 25
$-0.68
Q3 25
$-0.38
Q2 25
$-0.36
Q1 25
$-0.38
Q4 24
$-1.07
Q3 24
$-0.73
Q2 24
$-0.66
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SURG
SURG
USAS
USAS
Cash + ST InvestmentsLiquidity on hand
$1.7M
$39.1M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$-15.3M
$50.2M
Total Assets
$8.5M
$234.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SURG
SURG
USAS
USAS
Q4 25
$1.7M
Q3 25
$2.5M
$39.1M
Q2 25
$4.4M
Q1 25
$5.4M
Q4 24
$11.8M
Q3 24
$23.7M
Q2 24
Q1 24
Total Debt
SURG
SURG
USAS
USAS
Q4 25
$13.3M
Q3 25
$12.0M
Q2 25
$9.6M
Q1 25
$3.6M
Q4 24
$4.0M
Q3 24
$4.4M
Q2 24
$4.8M
Q1 24
$5.2M
Stockholders' Equity
SURG
SURG
USAS
USAS
Q4 25
$-15.3M
Q3 25
$-6.4M
$50.2M
Q2 25
$116.1K
Q1 25
$7.8M
Q4 24
$15.3M
Q3 24
$33.2M
$53.1M
Q2 24
$46.2M
Q1 24
$56.0M
Total Assets
SURG
SURG
USAS
USAS
Q4 25
$8.5M
Q3 25
$14.5M
$234.7M
Q2 25
$15.2M
Q1 25
$15.7M
Q4 24
$24.0M
Q3 24
$41.5M
Q2 24
$56.4M
Q1 24
$69.6M
Debt / Equity
SURG
SURG
USAS
USAS
Q4 25
Q3 25
Q2 25
82.67×
Q1 25
0.46×
Q4 24
0.26×
Q3 24
0.13×
Q2 24
0.10×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SURG
SURG
USAS
USAS
Operating Cash FlowLast quarter
$-3.6M
$-12.5M
Free Cash FlowOCF − Capex
$-41.3M
FCF MarginFCF / Revenue
-216.5%
Capex IntensityCapex / Revenue
150.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SURG
SURG
USAS
USAS
Q4 25
$-3.6M
Q3 25
$-4.6M
$-12.5M
Q2 25
$-6.1M
Q1 25
$-7.0M
Q4 24
$-7.9M
Q3 24
$-13.3M
$2.4M
Q2 24
$-4.1M
Q1 24
$4.0M
Free Cash Flow
SURG
SURG
USAS
USAS
Q4 25
Q3 25
$-41.3M
Q2 25
Q1 25
Q4 24
Q3 24
$-11.2M
Q2 24
Q1 24
FCF Margin
SURG
SURG
USAS
USAS
Q4 25
Q3 25
-216.5%
Q2 25
Q1 25
Q4 24
Q3 24
-42.2%
Q2 24
Q1 24
Capex Intensity
SURG
SURG
USAS
USAS
Q4 25
Q3 25
150.8%
Q2 25
Q1 25
Q4 24
Q3 24
51.2%
Q2 24
Q1 24
Cash Conversion
SURG
SURG
USAS
USAS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons